On February 2, 2017 Eisai Co., Ltd. reported financial results for the Nine-Month Period Ended December 31, 2016 (Report, Eisai, FEB 2, 2017, View Source [SID1234517643]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Know more, wherever you are:
Latest on How to Stay Tuned to 10 Major Cancer Meetings, book your free 1stOncology demo here.

Gross profit for the the nine-month periods ended December 2016 was 261.4 billion Yen in comparison to that of 277.2 billion Yen for the the nine-month period ended December 2015.

For Eisai’s detailed sales figures, View Source